IMCD Acquires Life Science Business of YCAM in South Korea
IMCD, a global distribution and formulation partner of specialty chemicals and ingredients, has agreed to acquire the personal care and pharmaceutical business of YCAM, a distributor based in South Korea.
Founded in 2010, YCAM specializes in distributing specialty ingredients for the cosmetics, personal care, and pharmaceutical markets. YCAM represents global suppliers and focuses on providing customers with formulation advice and specialty ingredients through its technical team and laboratory support, helping them stay abreast of market trends. YCAM is located in Anyang, South Korea, and generated a revenue of approximately KRW 26 billion (~ €17 million) in 2023.
"This acquisition will be an important step in expanding our footprint in our beauty and personal care market and further enriches our life science portfolio," remarked Dongjoon Lee, Managing Director of IMCD South Korea. "We are excited to welcome such a dedicated and skilled team to IMCD."
"I am convinced that YCAM’s extensive resources and knowledge can swiftly integrate into IMCD's global business model, enhancing its commercial and operational strength in South Korea's personal care and pharmaceuticals industries,” remarked Munkyum Kim, CEO of YCAM. “My team has been an invaluable asset to the company, and I believe they will have even more opportunities to develop and maximize their potential with IMCD."
The transaction is subject to closing conditions and is expected in the second quarter of 2025.
